Menu
  • Home
  • Upcoming Events
  • Industry Opportunities
  • Mentorship Program
  • Newsletter
    • Biotech Breakthroughs
      • SARS-CoV-2 Treatment and Vaccines
      • A Self-Orienting Device for Oral Delivery of Biomacromolecules
      • Synergistic ICB and Neoantigen Vaccine
      • Nanopore Protein Sequencing
    • Company Spotlights
      • Taysha Gene Therapies
      • Abbvie Inc.
      • Kaleido Biosciences
      • Gilead Sciences, Inc
      • Vertex Pharmaceuticals
      • Reata Pharmaceuticals
    • Industry Scientist Interviews
      • Biotech Career Roundtable 03/23/2021
      • Biotech Career Roundtable 11/18/20
      • Kristen Hege
      • Jonathan Rosenblum
      • Lucy Shapiro
      • Christian Cunningham
      • Kathy Brendza
      • John Butler
    • Biotech Market Trends
      • DNA Market
      • Cost Effectiveness of Drugs: Is ICER enough?
      • Checkpoint Inhibitor Market
      • The CRISPR Boom
      • Alzheimer's Detection and Treatment
      • RNAi
      • Microbiome Market
      • Chronic Kidney Disease
  • Our team
  • Contact
More

Biotech Breakthroughs

Concurrent delivery of ICB Improves Neoantigen Vaccine

Bo Li Lab observed synergy between immune checkpoint blockade with neoantigen vaccine.

Nanopore Protein Sequencing

Nanopore sequencing allows de novo protein sequencing at a single molecule resolution.

Avoiding Injections: Oral Biomacromolecule Delivery

The Langer Laboratory has developed a device to insert macromolecules through the stomach lining.

SARS-CoV-2 Update (11/25/20)

Read our updates on SARS-CoV-2 treatments and vaccines.

UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-5525
Powered by Webnode